+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free

Global Chondroitin Sulfate Market: Rising Prevalence of Osteoarthritis and Increasing Disposable Income to Boost Growth, says TMR

Posted on Dec 01, 2017

Qingdao WanTuMing Biological Products Co., Ltd., Sioux Pharm, Inc., TSI Group Ltd., Pacific Rainbow International, Inc., Yantai Ruikangda Biochemical Products Co., Ltd., Shandong Runxin Biotechnology Co., Ltd., and Summit Nutritionals International, Inc., are some of the most prominent players operating in the global chondroitin sulphate market, finds Transparency Market Research (TMR) in a new study. While a majority of the market players seek clinical trials of novel products as means to achieve competitive advantage, stringent regulations for approval often create hindrances. For instance, over-sulfated chondroitin sulfate was identified as a contaminant in heparin originating from China by the US Food and Drug Administration (FDA) in 2008.

This however did not deter companies from carrying out innovations. In April 2017, Gnosis got no objection GRAS from FDA for non-animal chondroitin, which is a good case in point for companies’ relentless efforts to obtain approvals for their innovation. Such conscious steps taken toward innovation will play a key role in catapulting players to fore and also in turn help the market impetus in the coming years.

According to TMR, the global chondroitin sulfate market is likely to exhibit a CAGR of 3.3% between 2017 and 2025. At this pace, the global chondroitin market will reach US$457.7 mn by the end of 2025, from US$343.9 mn in 2016. In terms of application, the dietary supplements segment is expected to hold the highest share in the global chondroitin sulfate market. Regionally, North America held the largest share in 2016. During the course of the forecast period, the North America market is expected to grow at a steady pace.

global chondroitin sulfate market

Emerging Nations to Exhibit Rising Demand for Chondroitin Sulfate

Various factors are likely to support the market’s growth. For instance, the rising disposable income of consumers and expanding economies are the chief drivers helping the market grow. Given the scenario, the market is expected to witness lucrative prospects in Asia Pacific. On account of the rising demand from Japan, China, Australia, and India, the Asia Pacific market for chondroitin sulfate will scale at a higher pace during the course of the report’s forecast period.

Typically obtained from animal sources such as cow cartilage and shark, chondroitin sulfate is usually found in cartilages around joints in a body. It is primarily used as an alternative medicine that can slow the progression of osteoarthritis or weak bones. In addition, chondroitin sulfate can reduce pain and inflammation, further improving joint functions. More often it is used with glucosamine. Furthermore, it finds considerable application in veterinary medicine. Chondroitin sulfate is also prescribed during heart diseases, HIV/AIDS, and scaly skin or psoriasis. Besides these, the rising use of chondroitin in eye drops for treating sore eyes, as a solution to preserve corneas used in transplants, and during cataract surgery have provided the market significant impetus in the last couple of years.

Cultural and Religious Inhibitions in Certain Nations may Pose Threat

Factors such as the increasing incidence of osteoarthritis worldwide, the rising awareness regarding joint health, and the launch of new chondroitin sulfate combinations will have positive impact on the overall market. On the downside, cultural and religious inhibitions across certain under-developed nations could pose threat to the global chondroitin sulfate market.

This review is based on a TMR report, titled “Global Chondroitin Sulfate Market - (Application – Pharmaceuticals, Dietary Supplements, Cosmetics, and Veterinary Use; Source – Bovine, Porcine, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025.”

The report segments the global chondroitin sulfate market as:

Global Chondroitin sulfate Market, by Application

  • Pharmaceutical
  • Dietary Supplements
  • Cosmetics
  • Veterinary Use

Global Chondroitin sulfate Market, by Source

  • Bovine
  • Porcine
  • Others

Global Interventional Radiology Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Israel
    • Rest of Middle East & Africa

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com

Back To Top